6505--Lab Supplies-Radiopharm |Consolidating 595, 642, 646 5 Year Indefinite Delivery/Indefinite Quantity (IDIQ) Radiopharmaceuticals |Xofigo, Illuccix, NETSPOT |
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), Network Contracting Office 4 (NCO4), has issued a Special Notice of Intent to Sole Source a consolidated five-year Indefinite Delivery/Indefinite Quantity (IDIQ) contract to Cardinal Health, 414, LLC. The requirement is for the delivery and inventory management of specific name-brand radiopharmaceuticals—Xofigo, Illuccix, and NETSPOT—for the Lebanon, Philadelphia, and Pittsburgh VA Medical Centers. Capability statements are due by February 13, 2026.
Scope of Work
The contractor will provide timely delivery and continuous inventory management for the following name-brand agents:
- Xofigo (Radium 223 dichloride): Used for castration-resistant prostate cancer with bone metastases.
- Illuccix (Gallium 68 PSMA-11): A PET imaging tracer for detecting prostate cancer cells.
- NETSPOT (Gallium 68 Dotatate): A PET tracer for neuroendocrine tumor diagnosis.
Key Requirements:
- Geographic Proximity: Due to the 68-minute half-life of these radiopharmaceuticals, the distributor must be located within the Pittsburgh, Philadelphia, and Lebanon areas.
- Licensing: Must hold current NRC and FDA licenses for producing and distributing radiopharmaceuticals.
- Technical Standards: Products must be barcode-labeled for compatibility with the VA’s Nuclear Medicine Information System (NMIS). Non-High Enriched Uranium (non-HEU) sources are preferred.
- Logistics: Includes quality control testing, hazardous material transport, and disposal of used/unused items.
Contract & Timeline
- Type: Firm-Fixed-Price IDIQ
- Duration: Five years (April 1, 2026 – March 31, 2031)
- Set-Aside: None (Intent to Sole Source to Cardinal Health)
- Response Due: February 13, 2026, at 10:00 AM EST
Evaluation
While the VA intends to sole source this requirement under FAR 6.103-11, it will evaluate capability statements to determine if a competitive procurement is in the government's best interest. If no viable responses are received, the VA will proceed with Cardinal Health.
Additional Notes
Interested vendors must submit a one-page capability statement including their UEI number, socioeconomic category, and a description of their ability to service all three specified VA locations.